{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:56:17Z","timestamp":1772578577813,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Japan Osteoporosis Foundation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.jocd.2012.02.005","type":"journal-article","created":{"date-parts":[[2012,10,27]],"date-time":"2012-10-27T04:37:13Z","timestamp":1351312633000},"page":"392-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Importance of Absolute Bone Mineral Density in the Assessment of Antiresorptive Agents Used for the Prevention of\u00a0Osteoporotic Fractures"],"prefix":"10.1016","volume":"15","author":[{"given":"Tatsuhiko","family":"Kuroda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocd.2012.02.005_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jocd.2012.02.005_bib2","first-page":"2405","article-title":"Relationship of health related quality of life to prevalent and new or worsening back pain in postmenopausal women with osteoporosis","volume":"32","author":"Silverman","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jocd.2012.02.005_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00198-003-1547-4","article-title":"Health-related quality of life and radiographic vertebral fracture","volume":"15","author":"Cockerill","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2012.02.005_bib4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00198-008-0761-5","article-title":"Sequential change in quality of life for patients with incident clinical fractures: a prospective study","volume":"20","author":"Hagino","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2012.02.005_bib5","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1001\/jama.285.21.2736","article-title":"Mortality and locomotion 6 months after hospitalization for hip fractures: risk factors and risk-adjusted hospital outcomes","volume":"285","author":"Hannan","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jocd.2012.02.005_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00198-003-1490-4","article-title":"Mortality after osteoporotic fractures","volume":"15","author":"Johnell","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2012.02.005_bib7","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(98)09075-8","article-title":"Mortality after all major types of osteoporotic fracture in men and women: an observational study","volume":"353","author":"Center","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jocd.2012.02.005_bib8","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archinte.159.11.1215","article-title":"Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group","volume":"159","author":"Kado","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jocd.2012.02.005_bib9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bone.2008.03.023","article-title":"Contributions of 25-hydroxyvitamin D, co-morbidities and bone mass to mortality in Japanese postmenopausal women","volume":"44","author":"Kuroda","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2012.02.005_bib10","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00198-009-1121-9","article-title":"Effects of bone mineral density of the lumbar spine and prevalent vertebral fractures on the risk of immobility","volume":"21","author":"Shiraki","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2012.02.005_bib11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jocd.2006.11.001","article-title":"Role of dual-energy X-ray absorptiometry in the diagnosis and treatment of osteoporosis","volume":"10","author":"Blake","year":"2007","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2012.02.005_bib12","series-title":"Assessment of osteoporosis at the primary health care level. Summary Report of a WHO Scientific Group","year":"2007"},{"key":"10.1016\/j.jocd.2012.02.005_bib13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s007740170001","article-title":"Osteoporosis Diagnostic criteria for primary osteoporosis: year 2000 revision","volume":"19","author":"Orimo","year":"2001","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jocd.2012.02.005_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2012.02.005_bib15","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/1529-0131(199906)42:6<1246::AID-ANR22>3.0.CO;2-U","article-title":"Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group","volume":"42","author":"Hochberg","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jocd.2012.02.005_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1210\/jcem.85.1.6267","article-title":"Antifracture efficacy of antiresorptive agents are related to changes in bone density","volume":"85","author":"Wasnich","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.02.005_bib17","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jcem.87.4.8415","article-title":"Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with anti-resorptive agents","volume":"87","author":"Hochberg","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.02.005_bib18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bone.2003.12.022","article-title":"Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy","volume":"34","author":"Delmas","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2012.02.005_bib19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1359\/JBMR.0301228","article-title":"Relationship between changes in bone mineral density and fracture risk reduction with antiresorptive drugs: some issues with meta-analyses","volume":"19","author":"Delmas","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2012.02.005_bib20","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1359\/JBMR.050814","article-title":"Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD","volume":"20","author":"Watts","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2012.02.005_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1359\/jbmr.2000.15.2.183","article-title":"Bone matters: are density increases necessary to reduce fracture risk?","volume":"15","author":"Faulkner","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2012.02.005_bib22","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.283.10.1318","article-title":"Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group","volume":"283","author":"Cummings","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jocd.2012.02.005_bib23","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/j.amjmed.2005.12.020","article-title":"Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?","volume":"119","author":"Bonnick","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jocd.2012.02.005_bib24","doi-asserted-by":"crossref","first-page":"b2266","DOI":"10.1136\/bmj.b2266","article-title":"Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data","volume":"338","author":"Bell","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jocd.2012.02.005_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9343(01)01124-X","article-title":"Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs","volume":"112","author":"Cummings","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.jocd.2012.02.005_bib26","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1359\/jbmr.1997.12.9.1438","article-title":"Association of bone mineral density with apolipoprotein E phenotype","volume":"12","author":"Shiraki","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2012.02.005_bib27","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/jbmr.5650110716","article-title":"Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The study of osteoporotic fractures research group","volume":"11","author":"Genant","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2012.02.005_bib28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2012.02.005_bib29","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/ard.16.4.494","article-title":"Radiological assessment of osteo-arthrosis","volume":"16","author":"Kellgren","year":"1957","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jocd.2012.02.005_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00774-004-0547-6","article-title":"Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004)","volume":"23","author":"Nishizawa","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jocd.2012.02.005_bib31","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1359\/jbmr.090818","article-title":"Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis","volume":"24","author":"Watts","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2012.02.005_bib32","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.12.002","article-title":"Impact of osteoporosis treatment adherence on fracture rates in North America and Europe","volume":"122","author":"Siris","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.jocd.2012.02.005_bib33","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2009-1947","article-title":"Long-term use of bisphosphonates in osteoporosis","volume":"95","author":"Watts","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.02.005_bib34","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jocd.2012.02.005_bib35","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1056\/NEJMct1004903","article-title":"Bisphosphonates for osteoporosis","volume":"363","author":"Favus","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2012.02.005_bib36","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1359\/jbmr.081247","article-title":"Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study","volume":"24","author":"Abrahamsen","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2012.02.005_bib37","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jocd.2012.02.005_bib38","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695012000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695012000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:37:09Z","timestamp":1761082629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695012000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1094695012000200"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2012.02.005","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Importance of Absolute Bone Mineral Density in the Assessment of Antiresorptive Agents Used for the Prevention of\u00a0Osteoporotic Fractures","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2012.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}